Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: Tau Mutations
Tau Tα1-3RT

Posted 3 March 2005

General Information

Transgene: Human tau minigene that overexpresses three human brain tau isoforms with 3RT was created in pKS vector by embedding a modified genomic version of tau exons 1 to 4 (containing introns that flank exons 2 and 3) in a cDNA for the shortest tau isoform (exons -1 to 13 without exons 4A, 6, 8, and 10). The tubulin Tα1 promoter was cloned into pcDNA3 vector, and the XmnI site on pcDNA3 was modified to an AscI site. Transgenic construct (Tα1-3RT) was made by ligating a SalI/PvuII fragment of the minigene construct into a KpnI/NotI-fragment of the Tα-1 promoter vector. The Tα1-3RT was cut, purified, microinjected into fertilized B6SJL/F1 mouse eggs, and reimplanted into pseudopregnant females. Line 14 with the highest transgene copy number and highest tau protein expression was propagated and used.

Promoter: Mouse tubulin Tα1 promoter

Mutation: Tau 3 human RT

Mouse strain: B6SJL, maintained as heterozygous

Phenotype

Neuropathological Analysis:

Generated a tau Tg mouse model of FTD that developed glial tau pathologies. Progressive accumulations of tau in astrocytes and oligodendrocytes were closely associated with degeneration of these cells as well as with disruption of myelin sheaths. Aged Tg mice showed numerous glial tau inclusions that were morphologically, histochemically, and immunohistochemically similar to the glial tau pathologies in FTDs, such as PSP, PiD, PSG, CBD, and FTDP-17.

Behavioral:

Mice developed progressive motor weakness, including impaired ability to stand on a slanted surface and dystonic movement of the hindlimbs or both hindlimbs and forelimbs when lifted by their tails. By 24 months of age, limb twitch was observed in 72% of Tg mice, compared with 18% of WT mice.

Availability

Virginia M. -Y. Lee
Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine
University of Pennsylvania School of Medicine
Philadelphia, PA 19104 USA
Phone: 215-662-6427
Fax: 215-349-5909
Email: vmylee@mail.med.upenn.edu

Patents:

References

Primary:

Higuchi M, Ishihara T, Zhang B, Ming Hong M, Andreadis A, Trojanowski J Q, and Lee V M-Y. Transgenic Mouse Model of Tauopathies with Glial Pathology and Nervous System Degeneration. Neuron 35:433-446, 2002. Abstract.

Associated:

Macknin J B, Higuchi M, Lee V M-Y, Trojanowski J Q and Doty R L. Olfactory dysfunction occurs in transgenic mice overexpressing human t protein. Brain Res. 1000:174-178, 2004. Abstract.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad